Trial intelligence / Profile preview

Efficacy and Safety of Yaz Flexible Extended Regimen for Contraception

NCT00567164Phase 3Completed

Sponsor
Bayer
Start
Oct 2007
Primary completion
Nov 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ethinyl estradiol + drospirenone in contraception, sponsored by Bayer. Started Oct 2007; status: completed.

02

Drugs

ethinyl estradiol + drospirenone
03

Conditions

contraception

Beyond the preview

Go deeper on NCT00567164.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00567164.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call